The single most important distinction GearCheck makes is between a marker result and its interpretation. A number without context is just a number. A number interpreted for who you are is actionable intelligence.
Imagine two people walk into the same lab and get the exact same blood test result. One is a 28-year-old strength athlete on a testosterone cycle. The other is a 60-year-old sedentary woman. The same number means completely different things. Standard lab reports cannot tell the difference. GearCheck can.
Here are five real examples that show how GearCheck's contextual rules transform the same raw result into a completely different interpretation depending on your profile, training, and AAS use.
eGFR is calculated from creatinine. Creatinine is produced by muscle. More muscle means more creatinine, which means lower eGFR. In a strength athlete, an eGFR of 74 is usually normal physiology. The same number in a 65-year-old sedentary woman would genuinely indicate CKD. Context is everything.
eGFR 74 mL/min
| Marker | Standard Interpretation | GearCheck Interpretation |
|---|---|---|
| Result | eGFR 74 mL/min | eGFR 74 mL/min |
| Assessment | Stage 2 CKD. Refer to nephrologist. | Expected for a strength athlete with high muscle mass. |
| Priority | ⚠️ ACTION | ✅ CONTEXTUAL (no action needed) |
| Next step | Repeat in 3 months, consider renal ultrasound. | Check Cystatin C to confirm. If normal, no follow-up needed. |
The contextual rule here is simple but powerful: eGFR from creatinine is unreliable in anyone with above-average muscle mass. The validation marker is Cystatin C, which is independent of muscle. If Cystatin C is normal, kidney function is normal regardless of what the eGFR calculation says. This single rule saves athletes from unnecessary nephrology referrals, anxiety, and invasive tests every single day.
The Kidney Rule in Practice
Abnormal kidney function. Stage 2 CKD. Referral to nephrology recommended. Repeat in 3 months.
Normal kidney function. Elevated creatinine from muscle mass. Cystatin C confirms healthy kidneys. No action needed.
Strength athletes training 4—6 days per week have chronically elevated AST and ALT from muscle microtrauma. The contextual rule checks CK (muscle damage marker) and GGT (liver-specific marker). If CK is high and GGT is normal, the AST elevation is muscle, not liver. The same AST of 85 in a non-training individual would genuinely warrant a liver workup.
AST 85 U/L
| Marker | Standard Interpretation | GearCheck Interpretation |
|---|---|---|
| Result | AST 85 U/L (ref < 40) | AST 85 U/L (ref < 40) |
| Assessment | Elevated liver enzymes. Investigate hepatitis, NAFLD, alcohol use. | Post-training muscle enzyme release. Check CK and GGT. |
| Priority | ⚠️ ACTION | ✅ CONTEXTUAL (if CK elevated + GGT normal) |
| Next step | Abdominal ultrasound, repeat in 2 weeks. | 5 days off training, retest. AST will drop. |
The key insight is that AST and ALT exist in both liver cells and skeletal muscle cells. GGT is found only in the liver. By checking the ratio and the corroborating markers, GearCheck distinguishes muscle leak from liver damage with high accuracy. For the athlete, this means a few days of rest instead of a full liver workup. For the non-athlete with genuinely elevated liver enzymes, it means no delay in diagnosis.
The Liver vs. Muscle Rule in Practice
Elevated liver enzymes. Possible NAFLD or medication-induced hepatotoxicity. Abdominal ultrasound recommended.
Muscle enzyme leak from training. CK confirms muscle origin. GGT is normal — liver is healthy. Rest 5 days and retest.
AAS pharmacologically suppress HDL by increasing hepatic lipase activity. An HDL of 28 mg/dL on blast is common and expected. The contextual rule checks whether the user is on cycle and, crucially, whether ApoB is elevated. ApoB is a stronger predictor of cardiovascular risk than HDL in isolation. If ApoB is normal, the low HDL is expected pharmacological noise that does not require intervention.
HDL 28 mg/dL
| Marker | Standard Interpretation | GearCheck Interpretation |
|---|---|---|
| Result | HDL 28 mg/dL (ref > 40) | HDL 28 mg/dL (ref > 40) |
| Assessment | Severely low HDL. High cardiovascular risk. | Expected on AAS. Compare to on-cycle baseline. |
| Priority | ⚠️ ACTION | 🔶 ATTENTION (not ACTION unless ApoB also elevated) |
| Next step | Start statin or niacin therapy. | Check ApoB. If < 110, monitor only. Retest off-cycle. |
This is one of the most common scenarios GearCheck handles. Standard labs flag nearly every AAS user's HDL as critically low. But the evidence shows that ApoB is a much better predictor of cardiovascular events than HDL. The contextual rule does not ignore the low HDL — it correctly prioritizes it based on the full lipid picture.
The Lipid Rule in Practice
Severely dyslipidemic. High cardiovascular risk. Statin therapy strongly recommended.
AAS-typical lipid pattern. ApoB is normal — no intervention needed for HDL alone. Retest off-cycle. Monitor ApoB as primary risk marker.
This is a case where the contextual rule agrees with the standard interpretation, but for different reasons. A hematocrit of 54% is actionable in both frameworks. However, GearCheck identifies the cause and targets the intervention at the root cause.
Hematocrit 54%
| Marker | Standard Interpretation | GearCheck Interpretation |
|---|---|---|
| Result | Hct 54% (ref < 50%) | Hct 54% (ref < 50%) |
| Assessment | Erythrocytosis. Risk of thrombosis. | AAS-stimulated erythropoiesis. Above 54% requires action. |
| Priority | ⚠️ ACTION | ⚠️ ACTION (same conclusion, different reasoning) |
| Next step | Phlebotomy, hematology referral. | Evaluate dose reduction, consider phlebotomy. Check platelets and blood pressure. |
The danger is real either way — a hematocrit above 54% increases blood viscosity and cardiovascular risk regardless of the cause. But the difference matters for treatment. Standard medicine might order a bone marrow biopsy to rule out polycythemia vera. GearCheck recognizes the AAS-stimulated erythropoiesis pattern and targets the intervention at the root cause: dose management, therapeutic phlebotomy if needed, and blood pressure monitoring.
The Hematology Rule in Practice
Erythrocytosis. Risk of thromboembolic events. Hematology referral for bone marrow biopsy to rule out PV.
AAS-stimulated erythropoiesis. Action required. Reduce dose or donate blood. Check BP. No bone marrow biopsy needed unless platelets are also elevated.
Creatinine reflects muscle mass, protein intake, and training status. A strength athlete weighing 100 kg with high protein intake will naturally have a higher creatinine than a sedentary individual. The contextual rule cross-references Cystatin C, which is independent of muscle mass.
Creatinine 1.4 mg/dL
| Marker | Standard Interpretation | GearCheck Interpretation |
|---|---|---|
| Result | Creatinine 1.4 mg/dL (ref < 1.2) | Creatinine 1.4 mg/dL (ref < 1.2) |
| Assessment | Elevated creatinine. Possible kidney impairment. | Elevated creatinine secondary to high muscle mass and high-protein diet. |
| Priority | ⚠️ ATTENTION | ✅ CONTEXTUAL (if Cystatin C normal) |
| Next step | Repeat creatinine, consider nephrology consult. | No action needed if Cystatin C and eGFR (Cystatin C) are normal. |
This rule alone prevents thousands of unnecessary medical consultations. Creatinine is a poor kidney marker in people with above-average muscle mass, yet standard labs continue to use it as the primary screening tool. The contextual fix is elegantly simple: just check Cystatin C. If it is normal, the kidneys are fine. The "elevated" creatinine is benign physiology.
The Creatinine Rule in Practice
Moderately reduced kidney function. eGFR below 60 = Stage 3a CKD. Repeat in 3 months. Nephrology consult if persistent.
Benign creatinine elevation from high muscle mass. Cystatin C is normal — kidney function is healthy. No follow-up needed. eGFR by Cystatin C would be > 90.
Each contextual rule follows the same logical pattern. Once you understand the structure, you can apply it to any marker:
Identify the Primary Signal
Check the Confounding Factor
Validate with a Specificity Marker
Adjust the Priority
Context Can Flip a Marker in Seconds
🔮A low eGFR is CKD in one person and normal in another. An elevated AST is liver damage or muscle recovery. Low HDL is a heart attack signal on a standard report and expected pharmacology on cycle. The same number means different things to different people.
— GearCheck Contextual Engine
- ✗Unnecessary kidney biopsies for low eGFR
- ✗Liver workups for training-elevated AST
- ✗Statins for benign on-cycle LDL elevation
- ✗Bone marrow biopsies for AAS-induced Hct
- ✓Normal eGFR with rising Cystatin C = hidden kidney stress
- ✓Rising GGT on oral AAS = genuine hepatotoxicity
- ✓Elevated ApoB with normal LDL = hidden cardiovascular risk
- ✓Suppressed SHBG with normal T = possible long-term suppression
